Company intelligence / Profile preview
Cancer Targeted Technology
Woodinville, Washington, United Statescancertargetedtechnology.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
Cancer Targeted Technology has developed a proprietary phosphoramidate-based scaffold that irreversibly binds to PSMA. Their lead diagnostic agent CTT1057 completed a Phase I clinical trial in metastatic prostate cancer patients with high specificity and sensitivity compared to standard scans. The company’s companion radiotherapeutic agent CTT1403 has advanced through IND-enabling studies. In January 2018, the PET imaging agent was licensed to Advanced Accelerator Applications/Novartis. The company recently received NIH Fast Track funding for further development of a PSMA-targeted chemotherapeutic prodrug for prostate cancer.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculesRadiopharmaceuticals (radiolabeled small molecules)Diagnostic imaging agents (PET tracers)Drug conjugates/prodrugs
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Advanced Accelerator Applications / Novartis (licensee of CTT1057 PET imaging agent)
Beyond the preview
Go deeper on Cancer Targeted Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cancer Targeted Technology.